Results of the phase 4 observational EXELS study of high-risk patients with essential thrombocythemia | Prof Claire Harrison at EHA 2015 - 101271

Spotlight
Video

Results of the phase 4 observational EXELS study of high-risk patients with essential thrombocythemia | Prof Claire Harrison at EHA 2015

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 20th Congress of the European Hematology Association (EHA), Claire Harrison, MD, DM, FRCP, FRCPath, of Guy's and St Thomas' NHS Foundation Trust, London, UK, discusses the results of the Evaluation of Xagrid Efficacy and Long-term Safety (EXELS) study. EXELS study is an observational phase 4 study that compared safety, pregnancy outcomes, and efficacy (measured by incidence of thrombohaemorrhagic events and platelet reduction) of anagrelide compared with other cytoreductive therapies in high-risk patients with essential thrombocythemia (ET).

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 06/25/15
Added : 3 years ago



Recommended

Nothing found.

More From EMJ

Nothing found.